These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH. Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458 [Abstract] [Full Text] [Related]
4. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Davies BI, Maesen FP, Baur C. Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287 [Abstract] [Full Text] [Related]
5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)]. Goto H, Takeda H, Kawai S, Watanabe S, Okazaki M, Shimada K, Nakano K, Yokouchi H, Mori T, Igari J, Oguri T, Yamamoto M, Kudo K, Kobayashi N, Tanaka T, Yoshimura K, Kawabata M, Nakamori Y, Sumitomo M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Aoki N, Honma Y, Suzuki Y, Karasawa Y, Oka M, Kobashi Y, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Oikawa S. Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644 [Abstract] [Full Text] [Related]
6. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. Davies BI, Maesen FP. J Antimicrob Chemother; 1999 Jun; 43 Suppl C():83-90. PubMed ID: 10404344 [Abstract] [Full Text] [Related]
7. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis. Chodosh S. Am J Med; 1991 Dec 30; 91(6A):93S-100S. PubMed ID: 1662900 [Abstract] [Full Text] [Related]
8. [An epidemiologic study of pathogenic agents found in acute exacerbations of chronic bronchitis in northern Spain]. Viejo Bañuelos JL, Fernández Jorge MA, Laparra Galíndez J. Arch Bronconeumol; 1998 Feb 30; 34(2):106. PubMed ID: 9580520 [No Abstract] [Full Text] [Related]
9. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis. Cazzola M, Di Perna F, Boveri B, Di Marco F, Diamare F, Centanni S. J Chemother; 2000 Jun 30; 12(3):216-22. PubMed ID: 10877516 [Abstract] [Full Text] [Related]
10. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N. Jpn J Antibiot; 1998 Jul 30; 51(7):437-74. PubMed ID: 9755430 [Abstract] [Full Text] [Related]
11. [Efficacy of lomefloxacin in treatment of patients with chronic bronchitis]. Fedoseev GB, Emel'ianov AV, Rudinskiĭ KA, Shevelev SE, Bykova AV. Antibiot Khimioter; 1998 Jul 30; 43(10):24-6. PubMed ID: 9825106 [Abstract] [Full Text] [Related]
12. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. Kemper P, Köhler D. Am J Med; 1992 Apr 06; 92(4A):98S-102S. PubMed ID: 1316079 [Abstract] [Full Text] [Related]
13. [Bacteria isolated from chronic upper and lower respiratory tract infections and the associated therapeutic strategies--in paranasal sinusitis]. Suzuki K. Kansenshogaku Zasshi; 2006 Jan 06; 80(1):13-8. PubMed ID: 16519120 [Abstract] [Full Text] [Related]
15. Ceftriaxone in acute purulent exacerbations of chronic bronchitis. Maesen FP, Davies BI, Teengs JP. J Antimicrob Chemother; 1984 Dec 06; 14(6):653-60. PubMed ID: 6097574 [Abstract] [Full Text] [Related]
16. The epidemiology of respiratory tract pathogens in southern Netherlands. Davies BI, Maesen FP. Eur Respir J; 1988 May 06; 1(5):415-20. PubMed ID: 3139445 [Abstract] [Full Text] [Related]
17. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ. Clin Ther; 1999 Jan 06; 21(1):172-88. PubMed ID: 10090434 [Abstract] [Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)]. Goto H, Takeda H, Kawai S, Watanabe T, Okazaki M, Shimada K, Nakano K, Yokouchi H, Ikemoto H, Mori T, Igari J, Oguri T, Yamamoto M, Inoue H, Nakadate T, Suwabe A, Ashino Y, Gejyo F, Okada M, Aoki N, Kitamura N, Suzuki Y, Karasawa Y, Kudo K, Kobayashi N, Tanaka T, Sumitomo M, Matsushima T, Oka M, Niki Y, Suga M, Tosaka M, Kohno S, Hirakata Y, Kondou A, Matsuda J, Nakano M, Nasu M, Hiramatsu K, Oikawa S. Jpn J Antibiot; 2006 Oct 06; 59(5):323-54. PubMed ID: 17180803 [Abstract] [Full Text] [Related]
19. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. Prigogine T, Glupczynski Y, Carpiaux JP, Blogie M, Yourassowsky E, Schmerber JS. J Antimicrob Chemother; 1988 Feb 06; 21 Suppl B():131-6. PubMed ID: 3129390 [Abstract] [Full Text] [Related]
20. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. Gotfried MH, Ellison WT. Am J Med; 1992 Apr 06; 92(4A):108S-113S. PubMed ID: 1316059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]